Daiken Medical Co., Ltd. - Laporan Laba Rugi (TTM)

Daiken Medical Co., Ltd.
JP ˙ TSE ˙ JP3482500000
JP¥ 463.00 ↑1.00 (0.22%)
2025-09-08
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Daiken Medical Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 8,046 8,038 7,861 8,048 8,176 8,266 8,540 8,759 8,908 9,016 9,137 9,302 9,507 9,647 9,750 9,784 9,840 10,010 9,951 10,054
Change (%) -0.10 -2.20 2.38 1.59 1.10 3.31 2.56 1.70 1.21 1.34 1.81 2.20 1.47 1.07 0.35 0.57 1.72 -0.58 1.03
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 4,491 4,496 4,503 4,630 4,681 4,760 4,856 5,029 5,201 5,333 5,607 5,729 5,826 5,879 5,768 5,746 5,772 5,882 5,855 6,015
Change (%) 0.11 0.16 2.82 1.10 1.69 2.02 3.56 3.42 2.54 5.14 2.18 1.69 0.91 -1.89 -0.38 0.45 1.91 -0.47 2.73
% of Revenue 55.82 55.93 57.28 57.53 57.25 57.59 56.86 57.42 58.39 59.15 61.37 61.59 61.28 60.94 59.16 58.73 58.66 58.77 58.84 59.83
Gross Operating Profit 3,555 3,542 3,358 3,418 3,495 3,506 3,684 3,730 3,707 3,683 3,530 3,573 3,681 3,768 3,982 4,038 4,068 4,127 4,096 4,039
Change (%) -0.37 -5.19 1.79 2.25 0.31 5.08 1.25 -0.62 -0.65 -4.15 1.22 3.02 2.36 5.68 1.41 0.74 1.45 -0.75 -1.40
% of Revenue 44.18 44.07 42.72 42.47 42.75 42.41 43.14 42.58 41.61 40.85 38.63 38.41 38.72 39.06 40.84 41.27 41.34 41.23 41.16 40.17
SG&A 1,949 1,936 1,943 1,945 1,967 2,004 2,092 2,099 2,076 2,055 2,105 2,097 2,116 2,075 2,539 2,238 2,234 2,307 2,209 2,642
Change (%) -0.67 0.36 0.10 1.13 1.88 4.39 0.33 -1.10 -1.01 2.43 -0.38 0.91 -1.94 22.36 -11.86 -0.18 3.25 -4.23 19.60
% of Revenue 24.22 24.09 24.72 24.17 24.06 24.24 24.50 23.96 23.30 22.79 23.04 22.54 22.26 21.51 26.04 22.87 22.70 23.04 22.20 26.28
R&D 488 488 448 448 448 448 382 382 382 382 316 316 316 316 249 249 249 332
Change (%) 0.00 -8.20 0.00 0.00 0.00 -14.73 0.00 0.00 0.00 -17.28 0.00 0.00 0.00 0.00 0.00 33.33
% of Revenue 6.07 6.07 5.70 5.57 5.48 5.42 4.47 4.36 4.29 4.24 3.46 3.40 3.32 3.28 2.54 2.53 2.49 3.34
OpEx 6,963 6,955 6,940 7,069 7,142 7,258 7,389 7,569 7,718 7,829 8,082 8,196 8,312 8,324 8,307 8,283 8,305 8,488 8,439 8,657
Change (%) -0.11 -0.22 1.86 1.03 1.62 1.80 2.44 1.97 1.44 3.23 1.41 1.42 0.14 -0.20 -0.29 0.27 2.20 -0.58 2.58
% of Revenue 86.54 86.53 88.28 87.84 87.35 87.81 86.52 86.41 86.64 86.83 88.45 88.11 87.43 86.29 85.20 84.66 84.40 84.80 84.81 86.11
Operating Income 1,083 1,083 921 979 1,034 1,008 1,151 1,190 1,190 1,187 1,055 1,106 1,195 1,323 1,443 1,501 1,535 1,522 1,512 1,397
Change (%) 0.00 -14.96 6.30 5.62 -2.51 14.19 3.39 0.00 -0.25 -11.12 4.83 8.05 10.71 9.07 4.02 2.27 -0.88 -0.63 -7.62
% of Revenue 13.46 13.47 11.72 12.16 12.65 12.19 13.48 13.59 13.36 13.17 11.55 11.89 12.57 13.71 14.80 15.34 15.60 15.20 15.19 13.89
Interest Expense -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -4 -4 -4 -4 -4 -5 -7 -9 -11
Change (%) -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 33.33 -0.00 -0.00 -0.00 -0.00 25.00 34.14 34.19 18.11
% of Revenue -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.04 -0.03 -0.03 -0.03 -0.03 -0.04 -0.04 -0.04 -0.04 -0.04 -0.05 -0.07 -0.09 -0.11
Net Income 795 797 675 715 725 705 831 857 860 857 712 754 820 912 988 1,033 1,059 1,057 1,097 1,024
Change (%) 0.25 -15.31 5.93 1.40 -2.76 17.87 3.13 0.35 -0.35 -16.92 5.90 8.75 11.22 8.33 4.55 2.52 -0.18 3.77 -6.69
% of Revenue 9.88 9.92 8.59 8.88 8.87 8.53 9.73 9.78 9.65 9.51 7.79 8.11 8.63 9.45 10.13 10.56 10.76 10.56 11.02 10.18

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista